Literature DB >> 29701595

Factors influencing advance directives among psychiatric inpatients in India.

Guru S Gowda1, Eric O Noorthoorn2, Peter Lepping3, Channaveerachari Naveen Kumar4, Raveesh Bevinahalli Nanjegowda5, Suresh Bada Math4.   

Abstract

OBJECTIVES: Advance directives are documents stating treatment preferences in case of future lack of decision making capacity. In India, as in many other countries, legislators advocate Psychiatric Advance Directives (PADs), while evidence on its use is limited. This study examined factors influencing PADs by gathering inpatients perspectives on PADs at discharge and investigating patient characteristics associated with the expression of treatment wishes in PADs.
METHODS: We conducted a hospital based descriptive study in Bangalore. 200 patients were included. The Mini International Neuropsychiatric Interview, CGI-S and CGI-I (Clinical Global Impression scales), the Insight Scale-2, and an Illness insight assessment were completed within 3days of admission. We used the Bangalore Advance Directive Interview (BADI) to assess attitudes towards PADs. 182 subjects were reassessed within 3days of discharge, along with an interview on their perspectives on PADs.
RESULTS: 67% welcomed the need for PADs in India. 95.6% made their own PADs. 80% followed their doctors' advice in their PAD. Subjects lacking insight or remaining symptomatic at discharge opted significantly more often against ECT, antipsychotics, and inpatient care. Linear regression showed that low socio-economic status, unwillingness to stay in hospital, and having received ECT before were inversely associated with the expression of treatment wishes in PADs.
CONCLUSIONS: This study's findings are relevant for India and Western countries alike while generating legislation including patients' perspectives. A majority of patients favoured PADs. Absent insight, severe psychopathology and incomplete recovery may negatively influence the way PADs are completed. Therefore, clinicians must assess patient's capacity to formulate PADs carefully, as capacity may significantly influence patients' views. The timing of when to formulate one's PAD within the illness process may be essential. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Capacity; India; Insight; Psychiatric advance directives; The Mental Health Care Act-2017

Mesh:

Year:  2017        PMID: 29701595     DOI: 10.1016/j.ijlp.2017.10.002

Source DB:  PubMed          Journal:  Int J Law Psychiatry        ISSN: 0160-2527


  5 in total

1.  How do Our Patients Respond to the Concept of Psychiatric Advance Directives? An Exploratory Study From India.

Authors:  Bheemsain Tekkalaki; Veerappa Y Patil; Sandeep Patil; Sameeran S Chate; Ramling Dhabale; Nanasaheb M Patil
Journal:  Indian J Psychol Med       Date:  2018 Jul-Aug

2.  Psychiatric Advance Directives Under the Convention on the Rights of Persons With Disabilities: Why Advance Instructions Should Be Able to Override Current Preferences.

Authors:  Matthé Scholten; Astrid Gieselmann; Jakov Gather; Jochen Vollmann
Journal:  Front Psychiatry       Date:  2019-09-11       Impact factor: 4.157

3.  Psychiatric Advance Directives and their relevance to improving psychiatric care in Asian countries.

Authors:  Daniel Poremski; Mark Alexander; Tina Fang; Giles Ming-Yee Tan; Samantha Ong; Alex Su; Daniel Fung; Hong Choon Chua
Journal:  Asia Pac Psychiatry       Date:  2019-12-23       Impact factor: 2.538

4.  Psychiatric advance directives for people living with schizophrenia, bipolar I disorders, or schizoaffective disorders: Study protocol for a randomized controlled trial - DAiP study.

Authors:  Aurélie Tinland; Léa Leclerc; Sandrine Loubière; Frederic Mougeot; Tim Greacen; Magali Pontier; Nicolas Franck; Christophe Lançon; Mohamed Boucekine; Pascal Auquier
Journal:  BMC Psychiatry       Date:  2019-12-27       Impact factor: 3.630

5.  Advance Decision Making in Bipolar: A Systematic Review.

Authors:  Lucy A Stephenson; Tania Gergel; Astrid Gieselmann; Matthé Scholten; Alex Ruck Keene; Larry Rifkin; Gareth Owen
Journal:  Front Psychiatry       Date:  2020-10-16       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.